Growth Metrics

Merck (MRK) Total Current Liabilities (2016 - 2025)

Merck (MRK) has disclosed Total Current Liabilities for 17 consecutive years, with $28.3 billion as the latest value for Q4 2025.

  • On a quarterly basis, Total Current Liabilities changed 0.33% to $28.3 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $28.3 billion, a 0.33% change, with the full-year FY2025 number at $28.3 billion, changed 0.33% from a year prior.
  • Total Current Liabilities was $28.3 billion for Q4 2025 at Merck, down from $28.6 billion in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $29.6 billion in Q3 2024 to a low of $21.9 billion in Q2 2021.
  • A 5-year average of $25.1 billion and a median of $24.7 billion in 2022 define the central range for Total Current Liabilities.
  • Peak YoY movement for Total Current Liabilities: fell 15.34% in 2022, then grew 28.11% in 2024.
  • Merck's Total Current Liabilities stood at $23.9 billion in 2021, then rose by 1.54% to $24.2 billion in 2022, then rose by 6.0% to $25.7 billion in 2023, then grew by 10.61% to $28.4 billion in 2024, then fell by 0.33% to $28.3 billion in 2025.
  • Per Business Quant, the three most recent readings for MRK's Total Current Liabilities are $28.3 billion (Q4 2025), $28.6 billion (Q3 2025), and $26.0 billion (Q2 2025).